Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-07 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0009 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |